2023 - Page 7 of 7

Interview with Ikeura, President and CEO of Axcelead, a holding company, was published in “PHARMA JAPAN”. 『Axcelead to Expand Overseas Biz, Shoots for 130 Billion Yen Sales and 5,000-Plus Researchers』

As a global CRDMO (Contract Research, Development and …

Michael Jaramillo2025-05-21T13:19:13+00:0004.20.2023|

Kanagawa, Japan, April 13, 2023 — We announced …

Michael Jaramillo2025-05-21T13:19:22+00:0004.13.2023|

Bioanalysis

Michael Jaramillo2023-12-01T05:45:27+00:0003.24.2023|

Kyoto and Kanagawa, Japan, March 10, 2023 — …

Michael Jaramillo2025-05-21T13:19:32+00:0003.10.2023|

CEO, Yoshi asked Dr. Fumihiro Jinno, who is head of …

Michael Jaramillo2024-05-31T22:13:05+00:0002.27.2023|

Tokyo, Japan, February 20, 2023 —

Michael Jaramillo2025-05-21T13:19:41+00:0002.20.2023|

Axcelead Drug Discovery Partners Inc. (Head Office: Fujisawa, …

Michael Jaramillo2025-05-21T13:19:49+00:0002.03.2023|

Future Science

Michael Jaramillo2023-12-01T05:46:44+00:0001.19.2023|

Kaken Pharmaceutical Co., Ltd. (“Kaken”, Head Office: Bunkyo-ku, …

Michael Jaramillo2025-05-21T13:20:03+00:0001.11.2023|

Stem Cell Research & Therapy

Michael Jaramillo2023-12-01T16:34:32+00:0001.05.2023|